ArticleInternational cancer conference journal2024

A patient who underwent conversion surgery after atezolizumab plus bevacizumab for hepatocellular carcinoma with portal vein thrombosis and perihepatic lymph node metastases achieved a pathological complete response.

Masayuki Okuno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.